UPDATE: Morgan Stanley Raises PT to $39 on GNC Holdings

Morgan Stanley increases its price target to $29 on Overweight-rated GNC Holdings

on continuing strength in sales. Morgan Stanley says, "We are raising our 2012e EPS and price target, as GNC's sales continue to impress, due to a robust new product cycle, and strong underlying vitamin/supplement industry demand. Line extensions should continue to drive comps in 2012, and the Lucky Vitamin acquisition opens a new internet sales opportunity." GNC closed at $34.68 a share on Tuesday.